Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 271INDUSTRY 250NETWORK 31NIH 30FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Palliative Care 2Methods 2Decision Support Techniques 2Cholecalciferol 2Calcitriol 2sulforaphane 1leucoselect phytosome 1apalutamide 1abiraterone 1Yoga 1Water 1Thioctic Acid 1Surgical Instruments 1Standard of Care 1Simvastatin 1Selective Serotonin Reuptake Inhibitors 1Radiosurgery 1Prednisone 1Perioperative Care 1Methylphenidate 1Leuprolide 1Indigo Carmine 1Hydroxymethylglutaryl-CoA Reductase Inhibitors 1Herpes Zoster Vaccine 1Golytely 1Gelatin 1Fluorouracil 1Exercise Test 1Enalapril 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
FED × Has results × Docetaxel × Clear all
NCT00132301 2018-06-25

CAP

VA Office of Research and Development

Phase 3 Completed
298 enrolled 18 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡